InsidersTradesSigma
Sunshine Biopharma, Inc: management transactions · United States · SEC (Form 4)
SEC:sunshine-biopharma-inc-6e9898US·SEC (Form 4)Mcap 4M€Healthcare
Browse the full insider trade history of Sunshine Biopharma, Inc, a listed issuer based in United States. Shares are quoted on US US, under the oversight of SEC (Form 4). Operating in the Healthcare sector, Sunshine Biopharma, Inc has recorded 2 insider filings. Market capitalisation: €4.4m. The latest transaction was disclosed on 6 June 2022 (Acquisition). Among the most active insiders: Sebaaly Camille. All data is free.
2
Insider Decl.
0
Thresholds
€28,369
1 ops.
Buy Volume
€87,098
1 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
0.89 €
Analyst consensus
1 analysts5.60 €Target 5.60 €(+531%)5.60 €
Income statement
Revenue36.3 M€
Gross profit12.3 M€34% margin
Net income−6.0 M€-17.0% margin
Valuation
P/Book0.2x
Balance sheet & cash
Market cap4.4 M€
Total debt812 k€
Free Cash Flow−6.2 M€
Debt / Equity3%
Profitability & ownership
ROE-27.3%
ROA-10.0%
% insiders2.0%
% institutions5.3%
Last declaration on 6 June 2022
Declarations0 total
No declarations found
0 of 0 declarations